Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)

Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication following kidney transplantation, and there is a critical and unmet need for PTLD treatments associated with more pronounced and durable responses. To date, reports on the use of CD19-targeted chimeric antigen re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kline, Kathryn, Chen, Wengen, Kallen, Michael E., Koka, Rima, Omili, Destiny, Fan, Xiaoxuan, Iraguha, Thierry, Gebru, Etse, Dishanthan, Nishanthini, Baker, Jillian M., Dietze, Kenneth A., Yared, Jean A., Hankey, Kim, Dahiya, Saurabh, Niederhaus, Silke V., Dunleavy, Kieron, Hardy, Nancy M., Luetkens, Tim, Rapoport, Aaron P., Atanackovic, Djordje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305491/
https://www.ncbi.nlm.nih.gov/pubmed/37278257
http://dx.doi.org/10.1080/21645515.2023.2216116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305491/
https://www.ncbi.nlm.nih.gov/pubmed/37278257
http://dx.doi.org/10.1080/21645515.2023.2216116

Ejemplares similares